ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
27.20
+0.65 (2.45%)
Mar 17, 2026, 4:00 PM EDT - Market closed
ARKG Holdings Information
ARKG is an equity ETF with a total of 33 individual holdings. The top holdings are Tempus AI stock at 9.65%, CRISPR Therapeutics AG at 9.34%, Twist Bioscience at 8.53%, Beam Therapeutics at 5.17%, and Personalis at 4.97%.
Total Holdings
33
Top 10 Percentage
59.20%
Asset Class
Equity
ETF Category
Health
Assets
1.04B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TEM | Tempus AI, Inc. | 9.65% |
| 2 | CRSP | CRISPR Therapeutics AG | 9.34% |
| 3 | TWST | Twist Bioscience Corporation | 8.53% |
| 4 | BEAM | Beam Therapeutics Inc. | 5.17% |
| 5 | PSNL | Personalis, Inc. | 4.97% |
| 6 | TXG | 10x Genomics, Inc. | 4.84% |
| 7 | NTRA | Natera, Inc. | 4.40% |
| 8 | ILMN | Illumina, Inc. | 4.28% |
| 9 | GH | Guardant Health, Inc. | 4.13% |
| 10 | RXRX | Recursion Pharmaceuticals, Inc. | 3.89% |
| 11 | NTLA | Intellia Therapeutics, Inc. | 3.71% |
| 12 | CDNA | CareDx, Inc. | 3.54% |
| 13 | VCYT | Veracyte, Inc. | 3.26% |
| 14 | ABSI | Absci Corporation | 2.71% |
| 15 | ADPT | Adaptive Biotechnologies Corporation | 2.58% |
| 16 | WGS | GeneDx Holdings Corp. | 2.50% |
| 17 | SDGR | Schrödinger, Inc. | 2.43% |
| 18 | NRIX | Nurix Therapeutics, Inc. | 2.42% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 2.01% |
| 20 | BFLY | Butterfly Network, Inc. | 1.95% |
| 21 | CMPS | COMPASS Pathways plc | 1.91% |
| 22 | PRME | Prime Medicine, Inc. | 1.65% |
| 23 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.61% |
| 24 | ATAI | AtaiBeckley Inc. | 1.46% |
| 25 | PACB | Pacific Biosciences of California, Inc. | 1.37% |
As of Mar 17, 2026